Retinal development and repair
We are working on cell therapy using the implantation of stem cell-derived retinal cells. This constitutes a therapeutic option for the treatment of retinal degenerative diseases, affecting photoreceptors and retinal pigment epithelial cells.
Presentation
Our team is at the forefront of the development of cell-based therapies to tackle degenerative diseases of the retina, such as hereditary retinal dystrophies and age-related macular degeneration (AMD). We focus on basic and translational research using human induced pluripotent stem (iPS) cells to create 3D retinal avatars, called retinal organoids, by recapitulating human retinogenesis.
The aims of our laboratory are to use these organoid models to gain a better understanding of the cellular and molecular events that occur during human retinal development, and to generate retinal cells and tissues that can be used for modelling retinal diseases and developing different types of cell therapy.
Research areas
- Pluripotent stem cells
- Organoids
- Cell therapy
- Disease Modeling
Team members
Scientific publications
Below you will find the latest scientific publications in this field: Retinal development and repair.